Clinical Trial Update: A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intravitreal injections of Macugen (pegaptanib sodium) given at least 7 days before vitrectomy for tractional retinal detachme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Retina Institute of Hawaii | Conditions: PDR | Phase 1 | Status: COMPLETED